Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer.

Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer. FASEB J. 2013 Jan; 27(1):45-50.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.